2m 2m 2m 2m 2m 2m 2m
TANGO THERAPETCS (TNGX)
NASDAQ
$28.40-$0.10 (-0.35%)
Price as of Jun 23, 2026 4:46 PM EDT- $4.6BMarket Cap
- 435.71%1-Year Change
- BiotechnologyIndustry
TANGO THERAPETCS (TNGX)
$28.40-$0.10 (-0.35%)
TNGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.50 | ||
Change | +$0.53 (+1.89%) | ||
Open | $28.52 | ||
High | $28.95 | ||
Low | $27.65 | ||
Previous Close | $27.97 | ||
Volume | 6,313,893 | ||
30-Day Average Volume | 5,611,278 | ||
1-Week Change | -13.37% | ||
1-Month Change | 40.81% | ||
1-Year Change | 435.71% | ||
3-Year Change | 726.09% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 162.8M | ||
Total Assets | $435.8M | ||
Market Cap | $4.6B | ||
Enterprise Value | $4.5B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$45.5M | ||
Free Cash Flow | -$44.4M | ||
EBIT | -$45.5M | ||
EBITDA | -$45.0M | ||
Net Working Capital | $378.0M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -99 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 12 | ||
P/E | -89 | ||
PEG | 23 | ||
Price/Free Cash Flow | -105 | ||
Price/Operating Cash Flow | -105 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue